Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Harmine | IC50 | 26.0 [1], 72.0 [2], 220.0 [3] | |
| (Z)-1-(3-Ethyl-5-methoxy-2,3-dihydrobenzothiazol-2-ylidene)propan-2-one | IC50 | 17.0 [1], 49.0 [2], 170.0 [3] | |
| 6-Bromoindirubin-3'-oxime | IC50 | 2100.0 [1] | |
| Kenpaullone | IC50 | 10000.0 [1] | |
| 5-Quinoxalin-6-ylmethylene-thiazolidine-2,4-dione | IC50 | 70.0 [1] | |
MLA | "Quest Database™ Dual specificty protein kinase CLK1 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Dec. 2025, https://www.aatbio.com/data-sets/dual-specificty-protein-kinase-clk1-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 21). Quest Database™ Dual specificty protein kinase CLK1 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/dual-specificty-protein-kinase-clk1-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |